A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

August 28, 2024

Primary Completion Date

March 16, 2025

Study Completion Date

April 14, 2025

Conditions
Obesity
Interventions
DRUG

Danuglipron

Danuglipron oral tablets

DRUG

Atorvastatin

Atorvastatin oral tablets

DRUG

Rosuvastatin

Rosuvastatin oral tablets

Trial Locations (3)

33143

Qps - Mra, Llc., South Miami

Qps-Mra, Llc, South Miami

92801

Anaheim Clinical Trials, LLC, Anaheim

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY